Table 2.
n | % | |
---|---|---|
Node Status | ||
Node Negative | 42,859 | 63.3% |
1-3 Nodes Positive | 16,648 | 24.6% |
>3 Nodes Positive | 8,191 | 12.1% |
Stage | ||
I | 31,721 | 46.9% |
II | 28,952 | 42.8% |
III | 7,025 | 10.4% |
Grade | ||
Well differentiated; Grade I | 14,813 | 21.9% |
Moderately differentiated; Grade II | 28,406 | 42.0% |
Poorly differentiated; Grade III | 23,191 | 34.3% |
Undifferentiated; anaplastic; Grade IV | 1,288 | 1.9% |
ER/PR/HER2 Status | ||
+/+/+ | 7,343 | 10.8% |
+/+/- | 36,906 | 54.5% |
+/-/+ | 2,258 | 3.3% |
+/-/- | 6,305 | 9.3% |
-/+/+ | 319 | 0.5% |
-/-/+ | 4,805 | 7.1% |
-/+/- | 652 | 1.0% |
-/-/- | 9,110 | 13.5% |
Tumor Size | ||
≤2 cm | 42,043 | 62.1% |
> 2 cm | 25,655 | 37.9% |
Race/Ethnicity | ||
Non-Hispanic White | 47,016 | 69.4% |
Non-Hispanic Black | 3,606 | 5.3% |
Hispanic | 10,134 | 15.0% |
Asian/Pacific Islander | 6,942 | 10.3% |
Age | ||
≤45 | 11,755 | 17.4% |
46-69 | 40,058 | 59.2% |
≥70 | 15,885 | 23.5% |
Total | 67,698 |